Published in Leukemia on February 18, 2010
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS One (2012) 2.09
HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant (2010) 2.04
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial. Biol Blood Marrow Transplant (2016) 0.78
Cell docking, movement and cell-cell interactions of heterogeneous cell suspensions in a cell manipulation microdevice. Sensors (Basel) (2011) 0.75
In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood (2005) 7.28
Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol (2007) 3.33
Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A (1988) 2.12
NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol (2002) 2.02
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. Blood Cells Mol Dis (2007) 1.11
Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference. Clin Immunol (2009) 1.04
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (1986) 14.34
Underdiagnosis and undertreatment of asthma in childhood. Br Med J (Clin Res Ed) (1983) 13.49
Prevalence and spectrum of asthma in childhood. Br Med J (Clin Res Ed) (1983) 9.44
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science (1994) 7.60
Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature (2008) 4.92
Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science (2000) 4.53
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol (1997) 4.51
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A (1988) 4.40
New insights to the MLL recombinome of acute leukemias. Leukemia (2009) 4.07
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev (1995) 3.81
Prevention and treatment of the complications of diabetes mellitus. N Engl J Med (1995) 3.66
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol (1998) 3.06
Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science (1988) 3.01
Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res (2001) 2.98
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med (1993) 2.85
Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun (1986) 2.80
GPU-based streaming architectures for fast cone-beam CT image reconstruction and demons deformable registration. Phys Med Biol (2007) 2.72
Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev (1996) 2.43
Ventilatory effects of laparoscopy under general anaesthesia. Br J Anaesth (1992) 2.30
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant (2006) 2.29
Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis (1999) 2.28
A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes. Mol Cell Biol (1990) 2.22
Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest (1999) 2.22
Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol (2001) 2.21
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant (2008) 2.10
Natural history of congenital kyphosis and kyphoscoliosis. A study of one hundred and twelve patients. J Bone Joint Surg Am (1999) 2.10
PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer. Mol Cell Biol (1993) 2.08
Cyclophotocoagulation: a report by the American Academy of Ophthalmology. Ophthalmology (2001) 2.04
Allogeneic blood stem cell transplantation: considerations for donors. Blood (1997) 2.03
Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther (2015) 2.03
Choice of toothbrush: a survey of dentists' personal preferences and recommendations for patients. Aust Dent J (1992) 2.02
Flat Refractive Geometry. IEEE Trans Pattern Anal Mach Intell (2011) 1.90
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull (1990) 1.84
PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J (1998) 1.84
New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens (2003) 1.81
Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science (1987) 1.76
Electron tomography of ice-embedded prokaryotic cells. Biophys J (1998) 1.73
PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity (1995) 1.72
Phototherapy induced hypocalcemia. Indian Pediatr (1998) 1.72
Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Anesth Analg (1997) 1.71
Differences in HLA class II alleles of isolated South American Indian populations from Brazil and Argentina. Hum Immunol (1993) 1.69
Kaposi's sarcoma in mainland Tanzania: a report of 117 cases. Br J Cancer (1969) 1.67
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med (1988) 1.67
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol (2005) 1.65
PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity (1997) 1.64
The effect of retrobulbar anesthesia on visual acuity in planned extracapsular cataract extraction. Ophthalmic Surg (1991) 1.64
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol (1998) 1.64
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients. Leukemia (2002) 1.62
Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology (1993) 1.62
Incorporation of 33P in soybean phosphatides. Biochim Biophys Acta (1970) 1.59
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood (1999) 1.58
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma. Cytotherapy (2006) 1.57
Quantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures, by use of 1,9-dimethylmethylene blue. Anal Biochem (1996) 1.56
Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J (1999) 1.56
Perinatal loss and parental bereavement. Am J Psychiatry (1989) 1.55
A retrospective audit of long-term lower limb complications following leg vein harvesting for coronary artery bypass grafting. Eur J Cardiothorac Surg (2003) 1.54
Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res (1998) 1.53
Corneal endothelial toxicity of topical anesthesia. Ophthalmology (1997) 1.52
The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat Res (1995) 1.50
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.48
One more use of ultrasound in ICU. Anaesthesia (2006) 1.48
Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol (1993) 1.48
The clinical diagnosis of Reiter's syndrome. Ophthalmic and nonophthalmic aspects. Ophthalmology (1986) 1.46
Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. Tissue Antigens (2003) 1.46
The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review. Diabet Med (2012) 1.44
Intranasal nitroglycerin and intraocular pressure during general anesthesia. Anesth Analg (1988) 1.43
Transfer of the minus strand of DNA during hepadnavirus replication is not invariable but prefers a specific location. J Virol (1995) 1.43
Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea. Clin Cancer Res (1999) 1.43
HTF4: a new human helix-loop-helix protein. Nucleic Acids Res (1991) 1.43
Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone. Hum Pathol (1994) 1.41
Rat bite as a cause of diabetic foot ulcer--a series of eight cases. Diabetologia (2006) 1.41
Transcription factors in lymphocyte development--T and B cells get together. Cell (1999) 1.41
Venous thrombosis associated with the placement of peripherally inserted central catheters. J Vasc Interv Radiol (2001) 1.40
Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. J Natl Cancer Inst (1993) 1.40
Transscleral and transcorneal iontophoresis of ketoconazole in the rabbit eye. Ophthalmology (1989) 1.40
Transplantation of CD34+ hematopoietic progenitor cells. Cancer Invest (1996) 1.40
Acute encephalopathy: a new toxicity associated with high-dose paclitaxel. Clin Cancer Res (1999) 1.40
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol (1988) 1.40
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion (1996) 1.40
Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy (2004) 1.40
Profile of young acute myocardial infarction in Harayana. J Assoc Physicians India (1998) 1.39
[Caroli disease: a case report and review of literature]. Acta Gastroenterol Latinoam (1998) 1.39
Symptomatic extreme bradycardia in obstructive jaundice. J Assoc Physicians India (1989) 1.39
Dissemination and commercialization of hematopoietic progenitor cell transplantation. J Hematother (1994) 1.39
The effect of age on neuromuscular transmission. J Physiol (1978) 1.38
Interferon-gamma inhibits collagen synthesis by human Tenon's capsule fibroblasts in vitro. Invest Ophthalmol Vis Sci (1991) 1.38
Modern prophylactic treatment of animal bite cases. J Indian Med Assoc (1993) 1.38
Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood (2001) 1.38
Ataxia telangiectasia. J Assoc Physicians India (1991) 1.37
Conjugation in archaea: frequent occurrence of conjugative plasmids in Sulfolobus. Plasmid (1998) 1.37
Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation. Anesthesiology (1996) 1.36
Phagocytosis by polymorphonuclear leukocytes of Staphylococcus aureus and Pseudomonas aeruginosa adherent to plastic, agar, or glass. J Immunol Methods (1983) 1.36
The Arden grating acuity: effect of age and optical factors in the normal patient, with prediction of the false negative rate in screening for glaucoma. Br J Ophthalmol (1981) 1.35
Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest (1995) 1.34